154 related articles for article (PubMed ID: 19842792)
1. Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.
De Mendoza C; Garrido C; Poveda E; Corral A; Zahonero N; Treviño A; Anta L; Soriano V
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):967-72. PubMed ID: 19842792
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.
Yebra G; de Mulder M; del Romero J; Rodríguez C; Holguín A
Antiviral Res; 2010 Feb; 85(2):409-17. PubMed ID: 20004217
[TBL] [Abstract][Full Text] [Related]
4. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
6. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes.
Anta L; Blanco JL; Llibre JM; García F; Pérez-Elías MJ; Aguilera A; Pérez-Romero P; Caballero E; Vidal C; Cañizares A; Gutiérrez F; Dalmau D; Iribarren JA; Soriano V; de Mendoza C;
J Antimicrob Chemother; 2013 Sep; 68(9):1994-2002. PubMed ID: 23629015
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
8. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010.
de Felipe B; Pérez-Romero P; Abad-Fernández M; Fernandez-Cuenca F; Martinez-Fernandez FJ; Trastoy M; Mata Rdel C; López-Cortés LF; Leal M; Viciana P; Vallejo A
Virol J; 2011 Aug; 8():416. PubMed ID: 21871090
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
[TBL] [Abstract][Full Text] [Related]
12. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
14. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
15. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
18. High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil.
Cardoso LP; Stefani MM
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):943-50. PubMed ID: 19792869
[TBL] [Abstract][Full Text] [Related]
19. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A
J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322
[TBL] [Abstract][Full Text] [Related]
20. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]